Accessing public market liquidity in high-density innovation ecosystems.
The Cambridge Stock Exchange Project is creating a platform for accessing liquidity from the market inside high-density innovation ecosystems across the UK.
The UK does a fantastic job of producing world-class science and technology companies - but loses them long before they reach their full potential.
The best UK companies are often prematurely acquired before the full scope of what they can achieve can be realised, or seek to relocate to the USA and are dislocated from their 'place of birth' ecosystems — resulting in significant economic lost opportunity costs for the UK.
Significant breaks in the funding continuum leave companies vulnerable to acquisition before they can reach scale.
Short, shallow funding cycles with limited options for market liquidity leave boards under pressure for a clean US acquisition.
At present, there is no access to liquid capital inside the innovation-led ecosystems of the UK.
Bridging private ecosystems and regulated capital markets.
The Cambridge Stock Exchange Project addresses a critical gap between local private funding ecosystems and capital markets by connecting high-potential UK science and technology ventures with aligned investors, strategic resources, and growth-stage support.
Through its strategic partnership with JP Jenkins, CSEP brings growth-stage companies from across the UK’s innovation ecosystems onto an FCA-regulated venue.
JP Jenkins provides the infrastructure for secondary market liquidity – giving companies a clear pathway to grow from within their home ecosystem.
- Matched bargain facility
- JP Jenkins Private Market (PISCES)
- Connected to over 50 UK-regulated brokers
Two audiences. One pathway.
Grow from within your home ecosystem.
If you are a high-potential UK science and technology company seeking access to regulated market liquidity, CSEP connects you with the infrastructure, strategic resources, and investor networks to grow from within your home ecosystem — preserving your scientific innovation, leadership, and economic contribution to the UK.
A transparent, regulated environment to trade.
JP Jenkins provides shareholders and prospective investors with a mechanism to buy and sell shares in a transparent, regulated environment — connecting over 50 UK-regulated brokers including IG Group, Hargreaves Lansdown, AJ Bell, interactive investor, and Winterflood Securities.
A structured path to regulated market liquidity.
Getting your company onto the JP Jenkins platform is a structured process. Here is what to expect.
Introduction
CSEP introduces your company to JP Jenkins in writing.
Qualification
Your company is assessed against agreed admission criteria. CSEP supports you through the documentation required to initiate onboarding.
Admission
JP Jenkins reviews your application and makes the admission decision at its sole discretion. Once admitted, your company joins an FCA-regulated venue connected to over 50 UK-regulated brokers.
Liquidity
Your company gains access to secondary market liquidity through JP Jenkins' matched bargain facility or JP Jenkins Private Market platform.
From first grant to main market listing.
The funding journey for a UK science and technology company is long, complex, and often poorly mapped. The CSEP Funding Continuum is a curated directory of capital providers, exchanges, and institutional partners at every stage of that journey.
CSEP is starting where the gap is greatest: connecting growth-stage UK companies with regulated market liquidity through our strategic partnership with JP Jenkins. The Continuum represents our broader ambition — to support the UK’s most promising ventures at every stage of their growth.
Stage 01
Grant Providers
+
Grant funding is typically the earliest form of non-dilutive capital available to UK science and technology companies. The providers listed here operate across government, corporate, and foundation sources — offering a starting point for ventures at the earliest stage of their journey.
Corporate
Stage 02
Pre-Seed
+
At the pre-seed stage, the right incubator, accelerator, or angel network can be as valuable as the capital itself. The organisations listed here operate across the UK’s key innovation clusters, supporting early-stage ventures with funding, infrastructure, and access to networks.
London / Oxford
Cambridge Cluster
National Networks
Stage 03
Seed
+
Seed funding marks the transition from idea to investable company. The providers listed here — spanning incubators, accelerators, angel networks, and early-stage funds — support ventures that have cleared initial validation and are building toward their first significant capital raise.
Life Sciences
Specialist Funds
Deep Tech
Stage 04
Series A JP Jenkins — CSEP Strategic Partner
+
Series A is where the funding continuum becomes harder to navigate. Institutional appetite exists, but access is uneven and the gap between private funding and market liquidity begins to widen. The providers listed here operate across the UK, USA, and Europe — offering Series A capital across a range of sectors.
For UK companies, CSEP’s strategic partnership with JP Jenkins provides access to secondary market liquidity.
Stage 05
Series B JP Jenkins — CSEP Strategic Partner
+
At Series B, companies have demonstrated commercial traction and are scaling. The pressure to access larger pools of capital — and to do so quickly — intensifies. The providers listed here operate across the UK, USA, and Europe, offering Series B capital to companies with proven growth trajectories.
For UK companies, CSEP’s strategic partnership with JP Jenkins provides access to secondary market liquidity.
Europe
Stage 06
Series C JP Jenkins — CSEP Strategic Partner
+
Series C represents a significant inflection point — companies at this stage are typically scaling rapidly, entering new markets, or preparing for a liquidity event. Capital requirements are larger and the investor base shifts toward institutional. The providers listed here operate across private equity, pension funds, and institutional investment channels.
For UK companies, CSEP’s strategic partnership with JP Jenkins provides access to secondary market liquidity.
Private Equity
Pension & Institutional
Growth Equity
Stage 07
Cambridge Stock Exchange Coming Soon
+
The Cambridge Stock Exchange is the long-term vision at the heart of the CSEP project — a dedicated exchange for the UK’s most promising science, technology, and green economy companies.
Coming Soon.
Stage 08
Stock Exchanges
+
For companies ready to pursue a main market listing, the exchanges listed here represent the principal venues available to UK science and technology companies globally. This is the horizon the CSEP Funding Continuum is built toward.
Stage 09
Managed Funds & ETFs
+
As companies grow and achieve greater market visibility, they may become eligible for inclusion in managed funds and ETFs. The funds listed here represent some of the principal vehicles through which institutional capital accesses the life science and technology sectors.
Latest from CSEP.
Ready to take the next step?
Whether you're a growth-stage company seeking market liquidity or an investor looking to access the UK's most promising ventures, the next step starts here.
